Physician profile
David Murray Mccarthy
NPI 1972535268
$402.98
in general payments reported to CMS, 2019-2025
11 companies · $99.53 in 2025
The $99.53 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.97 · 2021: $14.88 · 2022: $23.20 · 2023: $209 · 2024: $35.59 · 2025: $99.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $64.55 | 2023-2025 | Optimizer, Optimizer |
| Philips North America LLC | $63.84 | 2023-2025 | Holter |
| Novartis Pharmaceuticals Corporation | $53.89 | 2023 | |
| Amgen INC. | $41.96 | 2022-2025 | Repatha |
| Abbott Laboratories | $40.36 | 2024-2025 | Cardiomems, Jot Dx |
| Stryker Corporation | $38.79 | 2023 | N/A |
| Janssen Pharmaceuticals, INC | $28.09 | 2023 | Xarelto |
| Novo Nordisk INC | $20.97 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.69 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $16.96 | 2023 | Eliquis |
| Lantheus Medical Imaging, INC. | $14.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.